8-K/A XBRL

FORM 8-K/A

Company: NRX Pharmaceuticals, Inc.
Filed: November 22, 2023
Period of Report: November 15, 2023
Accession Number: 0001104659-23-120777

View Document ↗ View on SEC.gov ↗